RMTI
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E N/A, PEG 4.43, P/B 0.97
- P/B under 1.0
- Low P/S ratio
- Negative earnings make P/E irrelevant
- High PEG ratio (4.43)
Ref Growth rates and Earnings track record
- Analyst target price suggests potential upside
- Revenue growth is sharply negative (-25.6%)
- Earnings surprises are deeply negative
Ref Historical price trends
- 5-year price change of -90.9%
- Consistent trend of negative earnings
Ref Piotroski F-Score 1/9
- High current ratio
- Low debt/equity
- Piotroski F-Score of 1/9 indicates fundamental failure
Ref Yield N/A
- No dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for RMTI and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
RMTI
Rockwell Medical, Inc.
Primary
|
-90.9% | -57.7% | -11.7% | -22.2% | -11.7% | 0.0% |
|
RADX
Radiopharm Theranostics Limited
Peer
|
-74.1% | -74.1% | +6.5% | -35.6% | -2.5% | -1.7% |
|
PLUR
Pluri Inc.
Peer
|
-89.3% | -51.8% | -3.0% | -19.3% | +8.7% | +3.5% |
|
NMTC
NeuroOne Medical Technologies Corporation
Peer
|
-88.5% | -57.8% | +32.2% | -19.5% | +1.4% | -12.1% |
|
ATRA
Atara Biotherapeutics, Inc.
Peer
|
-98.9% | -95.6% | -24.7% | -54.9% | -70.3% | +15.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
RMTI
Rockwell Medical, Inc.
|
BEARISH | $36.0M | - | -15.3% | -7.7% | $0.91 | |
|
RADX
Radiopharm Theranostics Limited
|
BEARISH | $36.1M | - | -92.1% | -286.2% | $4.58 | Compare |
|
PLUR
Pluri Inc.
|
BEARISH | $35.28M | - | -% | -% | $3.51 | Compare |
|
NMTC
NeuroOne Medical...
|
BEARISH | $37.01M | - | -146.3% | -58.3% | $0.73 | Compare |
|
ATRA
Atara Biotherapeutics, Inc.
|
BEARISH | $37.64M | 1.83 | -% | 15.4% | $5.22 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-02 | NERI JESSE | Chief Financial Officer | Sale | 886 | $740 |
| 2026-01-02 | HUNTER HEATHER R. | Chief Operating Officer | Sale | 2,868 | $2,396 |
| 2025-11-18 | COOPER JOHN G | Director | Sale | 5,079 | $4,419 |
| 2025-11-17 | DAWSON JOSEPH H. | Director | Stock Award | 25,000 | - |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning RMTI from our newsroom.